馬來酸丙氯拉嗪市場：依適應症、劑型、配銷通路、地區

Prochlorperazine Maleate Market, By Indication, By Dosage Form, By Distribution Channel, By End User, By Geography

出版日期: 2023年11月16日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球馬來酸丙氯拉嗪市場規模為14.6億美元，預計2030年將達到18.5億美元，2023年至2030年複合年成長率為3.4%，預計還會成長。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	14.6億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	3.40%	2030年市場規模預測	18.5億美元

圖 1. 馬來酸丙氯拉嗪全球市場佔有率(%)（依地區），2023 年

馬來酸丙氯拉嗪用於治療嚴重噁心和嘔吐，並改善思覺失調症和焦慮症患者的情緒、思維和行為。它是吩噻嗪類藥物的一種。這種藥物的作用原理是透過影響大腦化學物質。因此身體可能會產生更多的多巴胺，這是一種有助於運動和愉悅的神經傳導物質。它還可能掩蓋導致噁心和嘔吐的更嚴重的疾病，例如藥物過量攝取或中毒、腦腫瘤、腦損傷和雷氏症候群。吩噻嗪類抗精神病藥物之一是馬來酸丙氯拉嗪。

市場動態：

在預測期內，嘔吐和噁心頻率的增加將繼續推動全球馬來酸丙氯拉嗪市場的成長。由於慢性病的增加和高齡化，需要止吐治療的人數正在增加。此外，患者意識的提高也將在預測期內繼續推動馬來酸丙氯拉嗪全球市場的成長。患者越來越願意尋找合適的替代療法並與醫療保健提供者討論他們的問題。在預測期內，聯合治療的創建可能為全球馬來酸丙氯拉嗪市場創造新的機會。含有馬來酸丙氯拉嗪的組合藥物的研究具有市場成長潛力。

預計安全問題和負面副作用將阻礙預測期內馬來酸丙氯拉嗪全球市場的成長。

本研究的主要特點

本報告對全球馬來酸丙氯拉嗪市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年成長率。
它還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
根據公司亮點、產品系列、主要亮點、業績和策略等參數對全球馬來酸丙氯拉嗪市場的主要企業進行了介紹。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
馬來酸丙氯拉嗪全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過分析全球馬來酸丙氯拉嗪市場時所使用的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 1.46 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	3.40%	2030 Value Projection:	US$ 1.85 Bn

Prochlorperazine maleate is utilized for treating severe nausea and vomiting as well as to help people with schizophrenia or anxiety have better moods, thinking, and conduct. It is a member of the phenothiazine class of drugs. The way this drug affects brain chemistry is how it functions. Dopamine, a neurotransmitter that aids in movement and pleasure, might then be produced in greater amounts by the body as a result. It can also mask more serious illnesses that produce nausea and vomiting, such as drug overdose or poisoning, brain tumors, brain injuries, or Reye's syndrome. A medicine from the phenothiazine class of antipsychotics is called prochlorperazine maleate.

Market Dynamics:

The increasing frequency of vomiting and nausea will continue to fuel growth of the global prochlorperazine maleate market over the forecast period. The number of people requiring antiemetic therapy is rising as a result of rising chronic disease prevalence and an aging population. Growing patient awareness will also continue to fuel growth of the global prochlorperazine maleate market over the forecast period. Patients are more active in seeking out the right therapy alternatives and talking about their issues with medical providers. The creation of combination therapies will create new opportunities for the global prochlorperazine maleate market over the forecast period. There is potential for market growth in the investigation of combination medicines containing prochlorperazine maleate.

Safety issues and negative side effects are expected to hamper growth of the global prochlorperazine maleate market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global prochlorperazine maleate market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prochlorperazine maleate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Pfizer Inc., Novartis AG, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., Johnson & Johnson, AbbVie Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Lupin Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prochlorperazine maleate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prochlorperazine maleate market

Global Prochlorperazine Maleate Market Detailed Segmentation:

By Indication:
- Nausea and Vomiting Management
- Vertigo
- Mental Health Disorders (e.g., Schizophrenia)
By Dosage Form:
- Oral Tablets
- Rectal Suppositories
- Injectable Formulations
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Homecare Settings
By Regions:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profile:
- GlaxoSmithKline plc
- Pfizer Inc.
- Novartis AG
- AstraZeneca plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sanofi S.A.
- Johnson & Johnson
- AbbVie Inc.
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Prochlorperazine Maleate, By Indication
- Market Prochlorperazine Maleate, By Dosage Form
- Market Prochlorperazine Maleate, By Distribution Channel
- Market Prochlorperazine Maleate, By End User
- Market Prochlorperazine Maleate, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Prochlorperazine Maleate Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Prochlorperazine Maleate Market , By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Nausea and Vomiting Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Vertigo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Motion Sickness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Prochlorperazine Maleate Market , By Dosage Form, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Rectal Suppositories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Injectable Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Prochlorperazine Maleate Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Prochlorperazine Maleate Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030,(US$ Bn)
North Africa
South Africa
Central Africa

9. Competitive Landscape

Sandoz Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan Pharmaceuticals Inc.
ABneal Pharmaceuticals LLC
Glenmark Pharmaceuticals Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd
Aspen Pharma Trading Limited
FAGRON
Sanofi
GlaxoSmithKline
Hikma Pharmaceuticals
Analyst Views